https://www.taxtmi.com/caselaws?id=89469 Thiabendazole Premix BP (Vet) was held not to be a patent or proprietary medicament for classification under sub-heading 3003.10. The product's presence in the British Pharmacopoeia supported its treatment as a recognised medicament, and the absence of an express reference to British Pharmacopoeia (Veterinary) in the tariff note did not, by itself, change that position. The label mark 'D' was found to be only a house mark identifying the manufacturer, not a product-specific brand name. A house mark used across a manufacturer's products does not convert a medicament into a patent or proprietary medicine. en-us Mon, 23 Nov 1998 00:00:00 +0530 Tue, 27 Sep 2011 12:40:29 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=89469 Thiabendazole Premix BP (Vet) was held not to be a patent or proprietary medicament for classification under sub-heading 3003.10. The product's presence in the British Pharmacopoeia supported its treatment as a recognised medicament, and the absence of an express reference to British Pharmacopoeia (Veterinary) in the tariff note did not, by itself, change that position. The label mark 'D' was found to be only a house mark identifying the manufacturer, not a product-specific brand name. A house mark used across a manufacturer's products does not convert a medicament into a patent or proprietary medicine. Case-Laws Central Excise Mon, 23 Nov 1998 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=89469